文献

J-GLOBAL ID：200902280035377713   整理番号：07A0431949

Alzheimer病でのドネペジルの長期認識利点:1994~1999と2000~2004年の間の後ろ向き比較

Long-term cognitive benefits of donepezil in Alzheimer’s disease: A retrospective comparison between 1994-1999 and 2000-2004

著者 (13件)： TOMITA Naoki (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  OOTSUKI Mari (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  MARUYAMA Masahiro (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  MATSUI Toshifumi (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  HIGUCHI Miyako (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  TSUTSUI Miho (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  SEKI Takashi (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  IWASAKI Koh (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  TAMAMIZU Masako (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  SOZU Takashi (Tokyo Univ. Sci., Tokyo, JPN) ,  YOSHIMURA Isao (Tokyo Univ. Sci., Tokyo, JPN) ,  FURUKAWA Katsutoshi (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  ARAI Hiroyuki (Tohoku Univ. Graduate School of Medicine, Miyagi)
資料名： Geriatrics & Gerontology International  (Geriatrics & Gerontology International)
巻： 7  号： 1  ページ： 41-47  発行年： 2007年03月 
JST資料番号： W1574A  ISSN： 1444-1586  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： ドネペジル治療を受けている現在(2000~2004年)とそれ...

シソーラス用語： ヒト ,...
準シソーラス用語： 後向き調査

   続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0431949&from=J-GLOBAL&jstjournalNo=W1574A") }}

分類 (1件)： 神経系疾患の薬物療法  (GN05020Y)

物質索引 (1件)： ドネペジル

引用文献 (26件)：

• HOMMA, A. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group. Dement Geriatr Cogn Disord. 2000, 11, 299-313
• ROGERS, SL. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998, 50, 136-145
• ROGERS, SL. Donepezil improves cognition and global function in Alzheimer disease : a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998, 158, 1021-1031
• WHITEHEAD, A. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease : a meta-analysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry. 2004, 19, 624-633
• LANCTOT, KL. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease : a meta-analysis. CMAJ. 2003, 169, 557-564

タイトルに関連する用語 (4件)： Alzheimer病 ,  ドネペジル ,  長期 ,  利点